Navigation Links
Milliman Says 2008 Medical Cost for 'American Family of Four' Exceeds $15,600
Date:5/14/2008

Employees' Share of Spending & Cost of Prescription Drugs Record

Double-Digit Increases

SEATTLE, May 14 /PRNewswire/ -- Milliman, Inc., one of the premier global consulting and actuarial firms, announced today that average total medical spending for its "typical American family of four" reached $15,609 in 2008, an increase of $1,109 over the preceding year. The finding is contained in the fourth annual Milliman Medical Index (MMI).

The MMI tracks the changes in average yearly healthcare costs when the family of four is covered by an employer-sponsored Preferred Provider Organization (PPO). The new Milliman study determined that the average annual medical cost for a family of four increased by 7.6% from 2007 to 2008. This was lower than the 8.4% average annual rate of increase for the period 2003-2007, but the burden of overall expense is steadily shifting to employees.

"The employee's share of spending on healthcare services rose by double digits for the second consecutive year in 2008," said study co-author Lorraine Mayne, a Milliman principal and consulting actuary. "We estimate the employees' portion of healthcare premiums increased 10.1% in 2008 over 2007. This is likely to increase pressure on the next presidential administration to address healthcare costs," Mayne added.

"The MMI examines the key drivers and the components of actual medical spending, including physician charges, prescription drugs and hospital charges," said Gary Brace, Milliman principal and study co-author. "Over the past year, the rate of prescription drug costs increased by double digits at 10.6%. This is a trend we expect will continue for several years, as fewer high volume drug patents expire. For many Americans, this rate of increase is exceeded only by fuel and certain food costs," Brace noted.

Medical costs for a family are determined by the number, type and cost of healthcare services that they utilize and the
'/>"/>

SOURCE Milliman, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Milliman Expert Addresses Practical Applications of Lifestyle-Based Analytics in Risk Selection
2. Milliman Survey Confirms Continued Dominance of Guarantees in Variable Annuity Retirement Income Products
3. Study Suggests Green Tea May Support the Medical Treatment of Stomach and Colon Cancer
4. Rising Medical Solutions and CEO Are Featured as a Case Study in the Effective Small Business Management, Ninth Edition Textbook
5. Blue Cross and Blue Shield of Illinois Names New Chief Medical Officer
6. China Sky One Medical, Inc. to Present at Brean Murray Carret & Co. All-Cap All-China Conference
7. China Sky One Medical, Inc. Announces Conference Call to Discuss First Quarter 2008 Results
8. Visage Imaging to Provide Fully Integrated Thin Client-Based Solution to Tufts Medical Center
9. Marc Feldmann and Sir Ravinder Maini win Dr. Paul Janssen Award for Biomedical Research
10. Providence Holy Cross Medical Center Ignores Community, Environmental Concerns With Planned Expansion of Mission Hills Facility
11. Emphasys Medical to Present VENT Clinical Trial Data at ATS 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...ralization ready at Passport .../ -- New vaccine requirements will affect,anyone w...o the U.S. and,anyone seeking adjustment of status...of of vaccinations against vaccine-preventable dis...ee on Immunization Practices.,Passport Health, a c...
(Date:7/23/2008)...rm count, motility, study finds , , THUR...lly invasive procedure can treat a common cause of...f having a baby, a new study finds. , The condi...lood vessels in the scrotum which prevents the nor...testicles. A minimally invasive radiological proce...
(Date:7/23/2008)...may be tough, but,Hollywood,s young stars like Lan...ing new smile to boost confidence. Cosmetic dentis...nts beam in on success, citing his,experience that...nce they,need for stardom. In agreement is Landon ...e designed by Dr. Kosdon., MTV,s Rock The Cradle ...
(Date:7/23/2008)...rouble, the worse their performance , , ...en suffering from coronary heart disease seem to f...And the longer the person had had heart disease, t...as reasoning, vocabulary and verbal fluency, accor...ean Heart Journal . , The research, however, ha...
Breaking Medicine News(10 mins):Health News:USCIS Tightens Vaccination Requirements 2Health News:Simple Procedure Improves Male Fertility 2Health News:Simple Procedure Improves Male Fertility 3Health News:Rock The Cradle's Bad Boy Landon Brown Owes His Irresistible New Smile to Dr. Michael Kosdon 2Health News:Coronary Disease Dulls Cognitive Skills 2
...a Corporation announced that, in conjunction with ...T), both parties have agreed for reasons of futil...) for the treatment of cystic fibrosis (CF). Genae...amine in prostate cancer, which is an investigator...
...li, daughter of Bangladeshi immigrants to the Unit...2007. Nora, 17, won the final competition, held i... than $60,000, The Daily Star said Wednesday, quot..."I just want to start a business and maybe even st...
...owth of Internet applications in healthcare has be...g increasingly involved in the healthcare service...acteristics that distinguish them from traditional...r in driving the use of the Internet in healthcare...
...en in Somerville town in Massachusetts are losing ... take notice. The kids of Somerville, a town of ...nutrition programme aimed at helping them learn he...hem throughout their lives. As a result the Somerv...
Other Medicine News:Health News:Genaera Discontinues Lomucin in Cystic Fibrosis Studies 2Health News:Benefits From the Use of the Internet in Healthcare Applications Highlighted 2Health News:Benefits From the Use of the Internet in Healthcare Applications Highlighted 3Health News:Somerville, A Town Committed to Tackle Obesity Among Kids 2Health News:Somerville, A Town Committed to Tackle Obesity Among Kids 3
(Date:7/22/2008)... and pegylated enzyme produces significantly en... - Pegylated enzyme well tolerated ...alozyme Therapeutics,Inc. (Nasdaq: HALO ), a bio...ing products targeting the extracellular matrix, t...inical animal efficacy data,for its pegylated-rHuP...
(Date:7/22/2008)...Approach of LASH (Laser Assisted Scar Healing)... MARSEILLES, France, July 22 /- Ekkyo...dicine company, which develops first-in-class,lase...tion, announced today,the publication of a scienti...orting the results of a pilot study on cutaneous s...
(Date:7/21/2008)... 2008 conferences, GAITHERSBURG, Md., July 21 /PR... company developing gene therapies for HIV and gen...6 Phase I and Phase II,clinical trials for the med...s an investigational gene therapy for the treatmen...rsday, July 24, 2008 at 11 a.m. EDT. The,presentat...
(Date:7/21/2008)...impedance spectroscopy (BIS) is,more accurate and ...ent of,lymphedema in breast cancer patients, accor...Journal of Clinical Oncology (2008; Vol. 26, Issue...t Cancer: Incidence, Risk Factors, and,Effect on U... Hayes, PhD.,and colleagues from Queensland Unive...
Breaking Medicine Technology:Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 2Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 5Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 2Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 3VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 2VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 3VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 4VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 5Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology 2Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology 3Into the wild 3447 1Life but not as we know it 3F 3443 1Life but not as we know it 3F 3443 2X rays often repeated for patients in developing countries 20385 1X rays often repeated for patients in developing countries 20385 2X rays often repeated for patients in developing countries 20385 3Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C Port 28R 29 Flex A 28R 29 Anastomosis System in His Practice and t 20381 1Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C Port 28R 29 Flex A 28R 29 Anastomosis System in His Practice and t 20381 2Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C Port 28R 29 Flex A 28R 29 Anastomosis System in His Practice and t 20381 3Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C Port 28R 29 Flex A 28R 29 Anastomosis System in His Practice and t 20381 4
...YTOWN, N.Y., June 15, 2007 /PRNewswire-FirstCall/ ... of scientific studies that,(1) demonstrate that A...ple types of human tumors in animal models, (2) re...cts, and (3) show that,MPC-6827 is not affected by...drug resistance. The study results appear in the J...
...HIGH WYCOMBE, England, June 18, 2007 /PRNewswire/ ...g how a new flu vaccine has the,potential to prote...demic and annual, was presented today by PepTcell,...VI (Options) Conference, in,Toronto, Canada. , The...the,European Journal of Immunology, showed how mic...
Other Medicine Technology:New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 2New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 3New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 4New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 5New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 6New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 2New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 3New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 4
...ll-natural moisturizing mist for the eyes develope...thers, from Oregon Health Sciences University's Ca...TEARS (2000) and dry eye patients showed, on avera...he eyes' tear film without disrupting the tear fil...
Finally, a camera that sees the way you do!,Combined with the MicroLux DVR (Digital Video Recorder), the MicroLux Headlight Camera System gives you an entirely new way to visualize, edit, share and
This latest sensor array with 275 channels gives an average inter-channel spacing of just 2.2 cm. This high-density array is particularly useful when using advanced analysis techniques, such as Synt
...ement position is achieved using an increased tilt...tient bed. The patient preparation can be carried ...ency the patient can be brought rapidly outside th...he integrated neck support increases patient safet...
Medicine Products: